US FDA Approved MediWound’s NexoBrid to Treat Serious Thermal Burns
MediWound Ltd. has announced that NexoBrid (anacaulase-bcdb), a treatment for adults with deep partial- or full-thickness thermal burns, has been approved by the U.S. Food and Drug Administration (FDA) for the removal of eschar. MediWound’s chief executive officer, Ofren Gonen, said that the FDA’s approval of NexoBrid, an innovative non-surgical treatment for severe burn injuries, […]
Continue Reading